iCubate? MDx

Rapid Syndromic Testing for All Labs The mission of iCubate? is to provide rapid, accurate and affordable syndromic testing to all laboratories to ensure care providers have the right tools to improve care and outcomes for their patients. The iCubate? team has developed the iC System?, a low-cost, fully automated, molecular diagnostic platform using armPCR technology, along with a suite of syndromic infectious diseases panels, including sepsis/positive blood cultures, upper / lower respiratory tract infections, GI, mycobacteria, and more. Why iCubate for your lab? ? Rapid syndromic testing for infectious diseases for better care, sooner ? Affordable system increasing accessibility for large and small labs ? Multiplex assay with high target specificity and sensitivity for actionable results ? 3 minutes of hands-on time with routine lab processes Twitter: @iCubate FDA Cleared Products iC-System? (iCubate’s platform) iC-GPC Assay? for Gram positive cocci Anticipated clearance 2019 iC-GN Assay? for Gram negative rods Robust Assay Pipeline GI, Respiratory, Mycobacterium

网站

https://www.icubate.com

iCubate? MDx的外部链接

所属行业

医疗设备制造业

规模

11-50 人

总部

Huntsville，AL

类型

私人持股

创立

2009

领域

Clinical Microbiology、Molecular Diagnostics、arm-PCR、Multiplex PCR、Syndromic Testing、Infectious Disease Diagnostics、Blood stream infection、gram positive cocci、gram negative rods和antimicrobial stewardship